Jet injectors have been delivering drugs and vaccines without needles since the Star Trek era, but never caught on widely in real-world medicine.... The needle and syringe are icons of modern medicine ...

Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use. PharmaJet injector pens are intended for needle-free subcutaneous delivery of a ...

PharmaJet’s intramuscular (IM) Needle-free Injection System - Stratis ® - was used to deliver Scancell’s iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 ...

DUBLIN--(BUSINESS WIRE)--The "Technology Landscape, Trends and Opportunities in the Global Needle Free Injection System Market" report has been added to ResearchAndMarkets.com's offering. This study ...

Needle-free drug injection company PharmaJet is close to completing a $5 million fundraising round of financing that would fund the production of 5 million syringes to deliver the polio vaccine.

DUBLIN--(BUSINESS WIRE)--The "Needle Free Injection System Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering. The future of the ...

Growth in Needle-Free Injection System market. Market Dynamics. Some key players. The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 ...

Amherst, N.H. - Long considered a novel technology with limited practical value, needle-free injection (NFI) is attempting to shed its image as an out-of-the-mainstream drug delivery technique. The ...

CSL Limited has inked an agreement with PharmaJet to enable its Afluria® influenza vaccine to be delivered with the PharmaJet Stratis® needle-free jet injector. The company plans to seek FDA approval ...

The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period. Growth ...

Maximilian de Courten has received funding from the NHMRC in the past. Maja Husaric and Vasso Apostolopoulos do not work for, consult, own shares in or receive funding from any company or organization ...